As of June 13, 2025, Synektik SA (SNT.WA) reports a Net Margin of 13.21%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Synektik SA's Net Margin
Over recent years, Synektik SA's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-09-30 | 13.21% |
| 2023-09-30 | 11.74% |
| 2022-09-30 | 6.17% |
| 2021-09-30 | 6.26% |
| 2020-09-30 | 7.03% |
This slight upward trend highlights how Synektik SA manages its overall profitability and cost control over time.
Comparing Synektik SA's Net Margin to Peers
To better understand Synektik SA's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Synektik SA (SNT.WA) | 13.21% |
| Mevis Medical Solutions AG (M3V.DE) | 26.87% |
| GPI SpA (GPI.MI) | 20.96% |
| EMIS Group PLC (EMIS.L) | 18.91% |
| ContextVision AB (CONTX.OL) | 18.89% |
| Pharmagest Interactive SA (PHA.PA) | 17.88% |
Compared to its competitors, Synektik SA's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.